Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
-
Research Paper Adds Clinical Anchors to Proposed Parkinson’s Staging System
-
-
MJFF launches program to expedite development of LRRK2-targeted therapies and biomarkers for Parkinson’s disease
-
Episode 24: Developing FLEXISyn to Identify and Measure Changes in Alpha-Synuclein in Parkinson's Disease with Judith Steen
-
Research Roundup: Recruiting Studies on Parkinson’s Progression and Symptoms
-
-
Episode 23: Clinical Applications of Biomarkers and Large-Scale Collaborative Research with Charles Adler

Join the Study that's Changing Everything
The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Patients First
Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."